AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Selective T-Cell Removal For Transplants

Detailed Technology Description

Title: Selective Trace Cancer Cell Removal for Stem-Cell Transplants Invention: This technology is a new method to identify, characterize, sort and remove trace amounts of cancer cells within a hematopoietic stem cell population ex vivo. This method helps to improve outcomes of stem cell transplantation. Background: Hematopoietic stem cell transplantations are increasingly used to help treat a variety of blood based cancers and pathologies. There are currently two main types of stem cell transplants; autologous (using your own cells) or allogenic (using donor cells). Both types of stem cell transplantations come with risks associated, including relapse of the cancer later on and graft vs. host disease. Therefore, improvements are needed to provide the right type of T-cell populations in order to decrease contaminating tumor cells and the chance of getting graft vs. host disease. Applications: Purification of hematopoietic stem cell transplantations Advantages:Faster than current sorting techniquesHigher specificityLess expensive Licensing Manager:Laura SilvaLauraS@tla.arizona.edu(520) 626-1557

Country/Region

USA

For more information, please click Here